microRNAs: New prognostic, diagnostic, and therapeutic biomarkers in cervical cancer. 2019

Javid Sadri Nahand, and Sima Taghizadeh-Boroujeni, and Mohammad Karimzadeh, and Sarina Borran, and Mohammad Hossein Pourhanifeh, and Mohsen Moghoofei, and Farah Bokharaei-Salim, and Sajad Karampoor, and Amir Jafari, and Zatollah Asemi, and Alireza Tbibzadeh, and Afshin Namdar, and Hamed Mirzaei
Department of Virology, Student Research Committee, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Cervical cancer is as a kind of cancer beginning from the cervix. Given that cervical cancer could be observed in women who infected with papillomavirus, regular oral contraceptives, and multiple pregnancies. Early detection of cervical cancer is one of the most important aspects of the therapy of this malignancy. Despite several efforts, finding and developing new biomarkers for cervical cancer diagnosis are required. Among various prognostic, diagnostic, and therapeutic biomarkers, miRNA have been emerged as powerful biomarkers for detection, treatment, and monitoring of response to therapy in cervical cancer. Here, we summarized various miRNAs as an employable platform for prognostic, diagnostic, and therapeutic biomarkers in the treatment of cervical cancer.

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D055088 Early Detection of Cancer Methods to identify and characterize cancer in the early stages of disease and predict tumor behavior. Cancer Screening,Cancer Screening Tests,Early Diagnosis of Cancer,Cancer Early Detection,Cancer Early Diagnosis,Cancer Screening Test,Screening Test, Cancer,Screening Tests, Cancer,Screening, Cancer,Test, Cancer Screening,Tests, Cancer Screening
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Javid Sadri Nahand, and Sima Taghizadeh-Boroujeni, and Mohammad Karimzadeh, and Sarina Borran, and Mohammad Hossein Pourhanifeh, and Mohsen Moghoofei, and Farah Bokharaei-Salim, and Sajad Karampoor, and Amir Jafari, and Zatollah Asemi, and Alireza Tbibzadeh, and Afshin Namdar, and Hamed Mirzaei
January 2019, Critical reviews in eukaryotic gene expression,
Javid Sadri Nahand, and Sima Taghizadeh-Boroujeni, and Mohammad Karimzadeh, and Sarina Borran, and Mohammad Hossein Pourhanifeh, and Mohsen Moghoofei, and Farah Bokharaei-Salim, and Sajad Karampoor, and Amir Jafari, and Zatollah Asemi, and Alireza Tbibzadeh, and Afshin Namdar, and Hamed Mirzaei
April 2016, World journal of gastrointestinal oncology,
Javid Sadri Nahand, and Sima Taghizadeh-Boroujeni, and Mohammad Karimzadeh, and Sarina Borran, and Mohammad Hossein Pourhanifeh, and Mohsen Moghoofei, and Farah Bokharaei-Salim, and Sajad Karampoor, and Amir Jafari, and Zatollah Asemi, and Alireza Tbibzadeh, and Afshin Namdar, and Hamed Mirzaei
November 2019, BMC cancer,
Javid Sadri Nahand, and Sima Taghizadeh-Boroujeni, and Mohammad Karimzadeh, and Sarina Borran, and Mohammad Hossein Pourhanifeh, and Mohsen Moghoofei, and Farah Bokharaei-Salim, and Sajad Karampoor, and Amir Jafari, and Zatollah Asemi, and Alireza Tbibzadeh, and Afshin Namdar, and Hamed Mirzaei
January 2013, Critical reviews in oncogenesis,
Javid Sadri Nahand, and Sima Taghizadeh-Boroujeni, and Mohammad Karimzadeh, and Sarina Borran, and Mohammad Hossein Pourhanifeh, and Mohsen Moghoofei, and Farah Bokharaei-Salim, and Sajad Karampoor, and Amir Jafari, and Zatollah Asemi, and Alireza Tbibzadeh, and Afshin Namdar, and Hamed Mirzaei
September 2017, Cell death & disease,
Javid Sadri Nahand, and Sima Taghizadeh-Boroujeni, and Mohammad Karimzadeh, and Sarina Borran, and Mohammad Hossein Pourhanifeh, and Mohsen Moghoofei, and Farah Bokharaei-Salim, and Sajad Karampoor, and Amir Jafari, and Zatollah Asemi, and Alireza Tbibzadeh, and Afshin Namdar, and Hamed Mirzaei
January 2013, Current topics in medicinal chemistry,
Javid Sadri Nahand, and Sima Taghizadeh-Boroujeni, and Mohammad Karimzadeh, and Sarina Borran, and Mohammad Hossein Pourhanifeh, and Mohsen Moghoofei, and Farah Bokharaei-Salim, and Sajad Karampoor, and Amir Jafari, and Zatollah Asemi, and Alireza Tbibzadeh, and Afshin Namdar, and Hamed Mirzaei
April 2018, Journal of cellular physiology,
Javid Sadri Nahand, and Sima Taghizadeh-Boroujeni, and Mohammad Karimzadeh, and Sarina Borran, and Mohammad Hossein Pourhanifeh, and Mohsen Moghoofei, and Farah Bokharaei-Salim, and Sajad Karampoor, and Amir Jafari, and Zatollah Asemi, and Alireza Tbibzadeh, and Afshin Namdar, and Hamed Mirzaei
February 2022, Molecular cancer,
Javid Sadri Nahand, and Sima Taghizadeh-Boroujeni, and Mohammad Karimzadeh, and Sarina Borran, and Mohammad Hossein Pourhanifeh, and Mohsen Moghoofei, and Farah Bokharaei-Salim, and Sajad Karampoor, and Amir Jafari, and Zatollah Asemi, and Alireza Tbibzadeh, and Afshin Namdar, and Hamed Mirzaei
August 2018, Journal of cellular biochemistry,
Javid Sadri Nahand, and Sima Taghizadeh-Boroujeni, and Mohammad Karimzadeh, and Sarina Borran, and Mohammad Hossein Pourhanifeh, and Mohsen Moghoofei, and Farah Bokharaei-Salim, and Sajad Karampoor, and Amir Jafari, and Zatollah Asemi, and Alireza Tbibzadeh, and Afshin Namdar, and Hamed Mirzaei
April 2024, Pharmacological reports : PR,
Copied contents to your clipboard!